Datové sady / Low Gravity Drug Stability Analyzer Project


Low Gravity Drug Stability Analyzer Project

Vydavatel National Aeronautics and Space Administration

Datum vydání před téměř 10 roky

US
beta

Shrnutí

Co poskytovatel nabízí?
a service or API for accessing open data

Databázová licence
Nevztahuje se

Licence na obsah
Creative Commons CCZero

Způsob ověření
ověřený automaticky

Popis

The goal of this proposed program through Phase III is to build a space-worthy Drug Stability Analyzer that can determine the extent of drug degradation. It will be able to monitor the drug active pharmaceutical ingredient (API) and its degradation product concentrations as a function of time, as well as determine if a drug is suitable for use. This will be accomplished by designing and building a rugged, small, low mass, low power, easy to use analyzer that can identify and quantify API and degradation products with little or no sample handling in 1 minute. Feasibility was successfully demonstrated during Phase I by measuring acetaminophen, azithromycin, epinephrine, lidocaine, and their degradation products in mixtures and during reaction with a 1-4% limit of detection. The API's were also successfully measured in commercial products. During the Phase II program a prototype Drug Stability Analyzer, suitable for space deployment will be built and used to measure the degradants of all the ISS medical kit drugs (>100) with an accuracy goal of 2% and a precision goal of 1% within 1 minute. The Drug Stability Analyzer will be transitioned from a TRL 3 to a 7 (ground tested).